KANJINTI vs TUKYSA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. KANJINTI and TUKYSA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KANJINTI	TUKYSA
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TRASTUZUMAB-ANNS	TUCATINIB
Manufacturer	Amgen Inc	Seagen
Dosage forms	Injectable	Tablet
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Gastrointestinal Neoplasms	Breast Neoplasms

kanjinti tukysa

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

TRASTUZUMAB-ANNS

TUCATINIB

Manufacturer

Amgen Inc

Seagen

Dosage forms

Injectable

Tablet

Drug class

—

Boxed warning

None

Treats

Breast Neoplasms, Gastrointestinal Neoplasms

Breast Neoplasms

Frequently asked questions

What is the difference between Kanjinti and Tukysa?

Kanjinti contains Trastuzumab-Anns, while Tukysa contains Tucatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.